Prostate Health Market - Trends Forecast Till 2028

Prostate Health Market, by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: December, 2021

Base Year Estimate: 2020

Report ID: D-PH-PHM-1061

Format:  

Number of Pages: 361

Domain: Pharmaceutical

Prostate Health Market – Trends Forecast Till 2028

The global Prostate Health market size is projected to reach USD 48.6 billion by 2026 at a CAGR of 9.1% from USD 31.9 billion in 2021 during the forecast period 2021-2028.

Prostrate is a gland in the human male reproductive system which is shaped like a walnut. It is located below the bladder and surrounds the urethra. Its basic size increase with increasing age but if the increase is more then it may result in the compression of the urethra leading to the non-passage of the urine.

Increased incidents of prostate cancer along with rising problem of obesity are some of the factors that have supported long-term expansion for Prostate Health Market.

The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. Due to the unfavourable policies and regulations the market has witnessed a sharp decline.

Prostate Health Market Growth Forecast

North America is expected to be the largest market of during the forecast period. The increasing population long with the increased incidents o BPH and prostate cancer and the high disposable income and rapid development in healthcare has led to the expansion of market in the region.

Prostate Health Market is segmented into Disease Indication and geography.

On the basis of disease indication

  • Prostate Cancer
    • AR Directed Therapies
    • Hormone ADT
    • Cytotoxic Agents
    • PARP Inhibitors
    • Others
  • Benign Prostate Hyperplasia
    • Alpha Blockers
      • Alfuzosin
      • Doxazosin
      • Tamsulosin
      • Silodosin
      • Other Alpha Blockers
    • 5 Alpha Reductase
      • Finasteride
      • Dutasteride
    • Others
  • Prostatitis
    • Prescription
    • Over the counter

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Prostate Health Market Primary Respondent

 

Key Players

  • Eli Lilly and Company
  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc.
  • Abbott
  • Astellas Pharma Inc.
  • Abbvie
  • Johnson & Johnson Services, Inc.

Recent Developments

  • In October 2020, Butterfly Medical received a funding of USD 7 million in a Series B round for the development of an anatomically shaped nitinol implant positioned in the prostatic urethra.
  • In February 2018, Zenflow a Californian start-up announced a USD 31.4-million Series A financing round to continue its minimally invasive approach to treating BPH.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Prostate Health market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 31.9 billion

Growth Rate

CAGR of 9.1% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD million and CAGR from 2021 to 2028

Report Segmentation

Disease indication and geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc. , GlaxoSmithKline plc. , Abbott , and Astellas Pharma Inc.

Available Customization

In addition to the market data for Prostate Health Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.